351 related articles for article (PubMed ID: 62761)
1. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
[TBL] [Abstract][Full Text] [Related]
2. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
Baltimore RS; Kasper DL; Baker CJ; Goroff DK
J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433
[TBL] [Abstract][Full Text] [Related]
3. Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.
Hastings MJ; Neil J; Easmon CS
Br J Exp Pathol; 1985 Jun; 66(3):317-23. PubMed ID: 3890914
[TBL] [Abstract][Full Text] [Related]
4. Neonatal cellular and humoral immunity to group B streptococci.
Hill HR; Shigeoka AO; Hall RT; Hemming VG
Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):787-94. PubMed ID: 388335
[TBL] [Abstract][Full Text] [Related]
5. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.
Anderson DC; Edwards MS; Baker CJ
J Infect Dis; 1980 Mar; 141(3):370-81. PubMed ID: 6988524
[TBL] [Abstract][Full Text] [Related]
6. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
Rainard P; Sarradin P; Poutrel B
Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
[TBL] [Abstract][Full Text] [Related]
8. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
9. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
10. An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.
Cleat PH; Coid CR
Br J Exp Pathol; 1982 Aug; 63(4):452-7. PubMed ID: 6817779
[TBL] [Abstract][Full Text] [Related]
11. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
Baker CJ; Edwards MS; Kasper DL
Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-human neutrophil antibodies in vitro. Quantitative studies.
Boxer LA; Stossel TP
J Clin Invest; 1974 Jun; 53(6):1534-45. PubMed ID: 4208468
[TBL] [Abstract][Full Text] [Related]
14. The role of opsonins in vacuolar sealing and the ingestion of zymosan by human neutrophils.
Kemp AS; Turner MW
Immunology; 1986 Sep; 59(1):69-74. PubMed ID: 3759128
[TBL] [Abstract][Full Text] [Related]
15. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
Anthony BF; Concepcion NF
Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
[TBL] [Abstract][Full Text] [Related]
16. Interaction between human neutrophils and group B streptococci (GBS) and group antigens, monitored by Luminol-dependent chemiluminescence.
Kowolik MJ; Cumming CG; Grant M
J Clin Lab Immunol; 1982 May; 8(1):55-8. PubMed ID: 7047747
[TBL] [Abstract][Full Text] [Related]
17. Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay.
Villaseñor-S A; Bryant AE; Stevens DL
J Infect Dis; 1999 May; 179(5):1293-6. PubMed ID: 10191240
[TBL] [Abstract][Full Text] [Related]
18. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
19. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
Fischer GW; Hunter KW; Wilson SR
Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
[TBL] [Abstract][Full Text] [Related]
20. The role of C3 in mediating binding and ingestion of group B streptococcus serotype III by murine macrophages.
Noel GJ; Katz SL; Edelson PJ
Pediatr Res; 1991 Jul; 30(1):118-23. PubMed ID: 1891276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
